The integration of differentially expressed genes based on multiple microarray datasets for prediction of the prognosis in oral squamous cell carcinoma

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.
   Google Scholar
• Sasahira T, Kirita T. Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma. Int J Mol Sci. 2018;19(8):2413. doi: 10.3390/ijms19082413. PMID: 30115834; PMCID: PMC6121568.
   Google Scholar
• Vattemi E, Claudio PP. The feasibility of gene therapy in the treatment of head and neck cancer. Head Neck Oncol. 2009;1:3.
   PubMedGoogle Scholar
• Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BIOCONDUCTOR. Bioinformatics. 2007;23(14):1846–1847.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.
   PubMed Web of Science ®Google Scholar
• Kolde R, Laur S, Adler P, et al. Robust rank aggregation for gene list integration and meta-analysis. Bioinformatics. 2012;28(4):573–580.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287.
   PubMed Web of Science ®Google Scholar
• Simon N, Friedman J, Hastie T, et al. Regularization paths for cox’s proportional hazards model via coordinate descent. J Stat Softw. 2011;39(5):1–13.
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu N, Guan X, et al. Immunosuppression induced by chronic inflammation and the progression to oral squamous cell carcinoma. Mediators Inflamm. 2016;2016:5715719.
   PubMed Web of Science ®Google Scholar
• Peltanova B, Raudenska M, Masarik M. Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review. Mol Cancer. 2019;18(1):63.
   PubMedGoogle Scholar
• Eckert AW, Kappler M, Grosse I, et al. Current Understanding of the HIF-1-Dependent Metabolism in Oral Squamous Cell Carcinoma. Int J Mol Sci. 2020;21(17):6083. doi: 10.3390/ijms21176083. PMID: 32846951; PMCID: PMC7504563.
   Google Scholar
• Aali M, Mesgarzadeh AH, Najjary S, et al. Evaluating the role of microRNAs alterations in oral squamous cell carcinoma. Gene. 2020;757:144936.
   PubMed Web of Science ®Google Scholar
• Momen-Heravi F, Trachtenberg AJ, Kuo WP, et al. Genomewide study of salivary MicroRNAs for detection of oral cancer. J Dent Res. 2014;93(7 Suppl):86S–93S.
   PubMed Web of Science ®Google Scholar
• Joseph JP, Harishankar MK, Pillai AA, et al. Hypoxia induced EMT: a review on the mechanism of tumor progression and metastasis in OSCC. Oral Oncol. 2018;80:23–32.
   PubMed Web of Science ®Google Scholar
• Smith BN, Bhowmick NA. Role of EMT in metastasis and therapy resistance. J Clin Med. 2016;5(2):17. doi: 10.3390/jcm5020017. PMID: 26828526; PMCID: PMC4773773.
   Web of Science ®Google Scholar
• Wu C, Chen W, Yu F, et al. Long noncoding RNA HITTERS protects oral squamous cell carcinoma cells from endoplasmic reticulum stress-induced apoptosis via promoting MRE11-RAD50-NBS1 complex formation. Adv Sci (Weinh). 2020;7(22):2002747.
   PubMedGoogle Scholar
• Liang J, Sun Z. Overexpression of membranal SLC3A2 regulates the proliferation of oral squamous cancer cells and affects the prognosis of oral cancer patients. J Oral Pathol Med. 2021;50(4):371–377.
   PubMed Web of Science ®Google Scholar
• Wu ZZ, Wang S, Yang QC, et al. Increased expression of SHMT2 is associated with poor prognosis and advanced pathological grade in oral squamous cell carcinoma. Front Oncol. 2020;10:588530.
   PubMed Web of Science ®Google Scholar
• Mohtasham N, Babakoohi S, Shiva A, et al. Immunohistochemical study of p53, Ki-67, MMP-2 and MMP-9 expression at invasive front of squamous cell and verrucous carcinoma in oral cavity. Pathol Res Pract. 2013;209(2):110–114.
   PubMed Web of Science ®Google Scholar
• Sterz C, Mandic R. [Cells of the tumor front: a potential therapeutic target in head and neck cancer therapy?]. HNO. 2013;61(12):1005–1010.
   PubMed Web of Science ®Google Scholar
• Liu J, Jiang X, Zou A, et al. circIGHG-induced epithelial-to-mesenchymal transition promotes oral squamous cell carcinoma progression via miR-142-5p/IGF2BP3 signaling. Cancer Res. 2021;81(2):344–355.
   PubMed Web of Science ®Google Scholar
• Carnielli CM, Macedo CCS, De Rossi T, et al. Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer. Nat Commun. 2018;9(1):3598.
   PubMedGoogle Scholar
• Ye H, Yu T, Temam S, et al. Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics. 2008;9:69.
   PubMed Web of Science ®Google Scholar
• Przybylo JA, Radisky DC. Matrix metalloproteinase-induced epithelial-mesenchymal transition: tumor progression at Snail’s pace. Int J Biochem Cell Biol. 2007;39(6):1082–1088.
   PubMed Web of Science ®Google Scholar
• Stott-Miller M, Houck JR, Lohavanichbutr P, et al. Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2011;20(12):2628–2636.
   PubMed Web of Science ®Google Scholar
• Chang YT, Chu LJ, Liu YC, et al. Verification of saliva matrix metalloproteinase-1 as a strong diagnostic marker of oral cavity cancer. Cancers (Basel). 2020;12:8.
   Web of Science ®Google Scholar
• Vihinen P, Kahari VM. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer. 2002;99(2):157–166.
   PubMed Web of Science ®Google Scholar
• Deraz EM, Kudo Y, Yoshida M, et al. MMP-10/stromelysin-2 promotes invasion of head and neck cancer. PLoS One. 2011;6(10):e25438.
   PubMed Web of Science ®Google Scholar
• Jin Y, Li Y, Wang X, et al. Dysregulation of MiR-519d affects oral squamous cell carcinoma invasion and metastasis by targeting MMP3. J Cancer. 2019;10(12):2720–2734.
   PubMed Web of Science ®Google Scholar
• Al-Azri AR, Gibson RJ, Keefe DM, et al. Matrix metalloproteinases: do they play a role in mucosal pathology of the oral cavity? Oral Dis. 2013;19(4):347–359.
   PubMed Web of Science ®Google Scholar
• Ren ZH, Wu K, Yang R, et al. Differential expression of matrix metalloproteinases and miRNAs in the metastasis of oral squamous cell carcinoma. BMC Oral Health. 2020;20(1):24.
   PubMed Web of Science ®Google Scholar
• Choudhry N, Sarmad S, Waheed NUA, et al. Estimation of serum matrix metalloproteinases among patients of oral squamous cell carcinoma. Pak J Med Sci. 2019;35(1):252–256.
   PubMed Web of Science ®Google Scholar
• Volpert M, Furic L, Hu J, et al. CRISP3 expression drives prostate cancer invasion and progression. Endocr Relat Cancer. 2020;27(7):415–430.
   PubMed Web of Science ®Google Scholar
• Wang Y, Sheng N, Xie Y, et al. Low expression of CRISP3 predicts a favorable prognosis in patients with mammary carcinoma. J Cell Physiol. 2019;234(8):13629–13638.
   PubMed Web of Science ®Google Scholar
• Ko WC, Sugahara K, Sakuma T, et al. Copy number changes of CRISP3 in oral squamous cell carcinoma. Oncol Lett. 2012;3(1):75–81.
   PubMed Web of Science ®Google Scholar
• Pal SK, Noguchi S, Yamamoto G, et al. Expression of myelin and lymphocyte protein (MAL) in oral carcinogenesis. Med Mol Morphol. 2012;45(4):222–228.
   PubMed Web of Science ®Google Scholar
• Ohkura S, Kondoh N, Hada A, et al. Differential expression of the keratin-4, −13, −14, −17 and transglutaminase 3 genes during the development of oral squamous cell carcinoma from leukoplakia. Oral Oncol. 2005;41(6):607–613.
   PubMed Web of Science ®Google Scholar
• Sakamoto K, Aragaki T, Morita K, et al. Down-regulation of keratin 4 and keratin 13 expression in oral squamous cell carcinoma and epithelial dysplasia: a clue for histopathogenesis. Histopathology. 2011;58(4):531–542.
   PubMed Web of Science ®Google Scholar
• Pawar H, Maharudraiah J, Kashyap MK, et al. Downregulation of cornulin in esophageal squamous cell carcinoma. Acta Histochem. 2013;115(2):89–99.
   PubMed Web of Science ®Google Scholar
• Santosh N, McNamara KK, Beck FM, et al. Expression of cornulin in oral premalignant lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;127(6):526–534.
   PubMed Web of Science ®Google Scholar
• Salahshourifar I, Vincent-Chong VK, Chang HY, et al. Downregulation of CRNN gene and genomic instability at 1q21.3 in oral squamous cell carcinoma. Clin Oral Investig. 2015;19(9):2273–2283.
   PubMed Web of Science ®Google Scholar